Bellevue Funds (Lux) - Bellevue Healthcare Strategy I2 Fonds
190,23
CHF
-0,22
CHF
-0,12
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Thermo Fisher Scientific Inc | US8835561023 | 4,24% |
| Galderma Group AG Registered Shares | CH1335392721 | 4,10% |
| AbbVie Inc | US00287Y1091 | 3,80% |
| Eli Lilly and Co | US5324571083 | 3,77% |
| UCB SA | BE0003739530 | 3,50% |
| Sandoz Group AG Registered Shares | CH1243598427 | 3,45% |
| HCA Healthcare Inc | US40412C1018 | 3,44% |
| McKesson Corp | US58155Q1031 | 3,25% |
| AstraZeneca PLC | GB0009895292 | 3,09% |
| Abbott Laboratories | US0028241000 | 2,93% |
| Sonstige | 64,44% |